ADC Therapeutics SA — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+36.4% +$6M
$23M
R&D↓-32.9% -$9M
$18M
D&A↓-100.0% -$341K
$0
Operating Income↑+12.9% +$5M
$-31M
EBITDA↓-100.0% -$341K
$0
Interest Expense↑+9.2% +$1M
$13M
Interest Income↓-10.7% -$281K
$2M
Other Income/Expense↓-43.0% -$699K
$925K
Pretax Income↑+6.1% +$3M
$-41M
Tax Provision↓-100.0% -$90K
$0
Net Income↑+6.8% +$3M
$-41M
Operating Margin↑+4.1pts
-188.5%
Net Margin↓-11.2pts
-249.4%
Effective Tax Rate↑+0.2pts
0.0%
ETR (Continuing Operations)↓-0.6pts
-0.7%
ETR Federal Statutory↑+0.0pts
7.8%
Pension Net Periodic Cost↓-41.2% -$47K
$67K
Revenue YoY Variation↑+35.6pts
36.4%
Income YoY Variation↑+11.3pts
12.9%
Revenue QoQ Variation↑+48.8pts
40.4%
Income QoQ Variation↑+52.3pts
29.9%